高级检索
当前位置: 首页 > 详情页

Redefined hyponatremia as a marker to exclude the diagnosis of anastomotic leakage after colorectal cancer surgery

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of General Surgery, China-Japan Friendship Hospital, Beijing, China [2]Department of Emergency Medicine, China-Japan Friendship Hospital, Beijing, China
出处:
ISSN:

关键词: Hyponatremia colorectal cancer anastomotic leakage leukocytosis biomarker postoperative serum sodium level

摘要:
Objective Our objective was to investigate the association between anastomotic leakage (AL) and hyponatremia after colorectal cancer surgery. Methods All anastomoses in colorectal cancer surgery performed in our hospital between January 2015 and December 2017 were retrospectively identified. According to the diagnostic criteria of AL, the patients were divided into an AL group and a no anastomotic leakage (NAL) group. Results We reviewed records of 498 consecutive colorectal cancer patients. The total incidence of AL was 5.4%. Postoperative serum sodium levels differed significantly: 137.63 +/- 4.29 and 139.81 +/- 3.41 mmol/L in the AL and NAL groups, respectively. By using area under the receiver-operating characteristic (auROC) curves, we determined the optimum postoperative serum sodium cut-off to be 139.5 mmol/L and redefined hyponatremia as postoperative serum sodium <139.5 mmol/L. Redefined hyponatremia had an auROC of 0.65, corresponding to a 97.2% negative predictive value. The negative predictive value reached 99.1% when serum sodium level was combined with leukocytosis. Multivariable analysis found that redefined hyponatremia (odds ratio, 1.176) was an independent predictive factor for AL. Conclusions Redefined hyponatremia has good negative predictive value for AL diagnosis after colorectal cancer surgery and could be used as a marker to exclude the diagnosis.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验 4 区 药学
JCR分区:
出版当年[2018]版:
Q4 PHARMACOLOGY & PHARMACY Q4 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q4 MEDICINE, RESEARCH & EXPERIMENTAL Q4 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2018版] 出版当年五年平均[2014-2018] 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Department of General Surgery, China-Japan Friendship Hospital, Beijing, China
通讯作者:
通讯机构: [1]Department of General Surgery, China-Japan Friendship Hospital, Beijing, China [*1]Department of General Surgery, China-Japan Friendship Hospital, Yinghua East Road, Chaoyang District, Beijing 100029, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:817 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)